Next-Gen MOF Biopreservation: Decentralized Sample Tech

The original patent disclosed methods and systems for preparing and preserving biological samples using metal-organic framework (MOF) encapsulants. However, these methods have limitations in terms of scalability, portability, and adaptability to diverse sample types and collection settings. The new invention addresses these limitations by envisioning next-generation systems that can preserve biological samples in resource-limited settings, decentralized point-of-care settings, and even on the human body.

The new claims introduce several novel and non-obvious features, including the use of wearable, flexible substrates; autonomous, robotic devices; and custom-designed, adaptive MOF materials. These features enable the preservation of biological samples in unprecedented ways, such as on the human body or in decentralized settings.

Alternative embodiments may include the use of different types of MOF materials, substrates, or microfluidic devices. Variations may include integrating the systems with artificial intelligence, blockchain technology, or other data management platforms to enhance their functionality and security.

The next-generation biological sample preservation systems have vast commercial potential in industries such as healthcare, biotechnology, and pharmaceuticals. They can enable decentralized, point-of-care diagnostics, remote patient monitoring, and personalized medicine, among other applications.